265 related articles for article (PubMed ID: 10606873)
1. Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease patients.
Bladon J; Taylor PC
Br J Haematol; 1999 Dec; 107(4):707-11. PubMed ID: 10606873
[TBL] [Abstract][Full Text] [Related]
2. Successful implementation of a rural extracorporeal photopheresis program for the treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease in a rural hospital.
Weber LL; Dunbar NM; Meehan KR; Szczepiorkowski ZM; Lansigan F
J Clin Apher; 2015 Dec; 30(6):359-63. PubMed ID: 25691106
[TBL] [Abstract][Full Text] [Related]
3. Extracorporeal photopheresis in cutaneous T-cell lymphoma and graft-versus-host disease induces both immediate and progressive apoptotic processes.
Bladon J; Taylor PC
Br J Dermatol; 2002 Jan; 146(1):59-68. PubMed ID: 11841367
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal photopheresis reduces the number of mononuclear cells that produce pro-inflammatory cytokines, when tested ex-vivo.
Bladon J; Taylor P
J Clin Apher; 2002; 17(4):177-82. PubMed ID: 12494410
[TBL] [Abstract][Full Text] [Related]
5. Comparison between 8-methoxypsoralen and 5-aminolevulinic acid in killing T cells of photopheresis patients ex vivo.
Holien T; Gederaas OA; Darvekar SR; Christensen E; Peng Q
Lasers Surg Med; 2018 Jul; 50(5):469-475. PubMed ID: 29460964
[TBL] [Abstract][Full Text] [Related]
6. Extracorporeal photopheresis: what is it and when should it be used?
Scarisbrick J
Clin Exp Dermatol; 2009 Oct; 34(7):757-60. PubMed ID: 19663836
[TBL] [Abstract][Full Text] [Related]
7. Early reduction in number of T cells producing proinflammatory cytokines, observed after extracorporeal photopheresis, is not linked to apoptosis induction.
Bladon J; Taylor PC
Transplant Proc; 2003 Jun; 35(4):1328-32. PubMed ID: 12826151
[TBL] [Abstract][Full Text] [Related]
8. Photopheresis in cutaneous T-cell lymphoma: five-year experience.
Crovetti G; Carabelli A; Berti E; Guizzardi M; Fossati S; De Filippo C; Bertani E
Int J Artif Organs; 2000 Jan; 23(1):55-62. PubMed ID: 12118838
[TBL] [Abstract][Full Text] [Related]
9. Biological quality control for extracorporeal photochemotherapy: Assessing mononuclear cell apoptosis levels in ECP bags of chronic GvHD patients.
Taverna F; Coluccia P; Arienti F; Birolini A; Terranova L; Mazzocchi A; Rini F; Mariani L; Melani C; Ravagnani F
J Clin Apher; 2015 Jun; 30(3):162-70. PubMed ID: 25220858
[TBL] [Abstract][Full Text] [Related]
10. The down-regulation of IL1alpha and IL6, in monocytes exposed to extracorporeal photopheresis (ECP)-treated lymphocytes, is not dependent on lymphocyte phosphatidylserine externalization.
Bladon J; Taylor PC
Transpl Int; 2006 Apr; 19(4):319-24. PubMed ID: 16573548
[TBL] [Abstract][Full Text] [Related]
11. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group.
McKenna KE; Whittaker S; Rhodes LE; Taylor P; Lloyd J; Ibbotson S; Russell-Jones R; ;
Br J Dermatol; 2006 Jan; 154(1):7-20. PubMed ID: 16403088
[TBL] [Abstract][Full Text] [Related]
12. The role of extracorporeal photopheresis in the management of cutaneous T-cell lymphoma, graft-versus-host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society.
Alfred A; Taylor PC; Dignan F; El-Ghariani K; Griffin J; Gennery AR; Bonney D; Das-Gupta E; Lawson S; Malladi RK; Douglas KW; Maher T; Guest J; Hartlett L; Fisher AJ; Child F; Scarisbrick JJ
Br J Haematol; 2017 Apr; 177(2):287-310. PubMed ID: 28220931
[TBL] [Abstract][Full Text] [Related]
13. Mini buffy coat photopheresis for children and critically ill patients with extracorporeal photopheresis contraindications.
Hackstein H; Misterek J; Nockher A; Reiter A; Bein G; Woessmann W
Transfusion; 2009 Nov; 49(11):2366-73. PubMed ID: 19903292
[TBL] [Abstract][Full Text] [Related]
14. Extracorporeal Photopheresis and Its Use in Clinical Dermatology in Canada.
Lagacé F; Netchiporouk E; Turchin I; Gulliver W; Dutz J; Kirchhof MG; Popradi P; Gniadecki R; Lynde C; Litvinov IV
Skin Therapy Lett; 2022 Sep; 27(5):1-6. PubMed ID: 36469458
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphoma and chronic graft-versus-host-disease patients.
Quaglino P; Comessatti A; Ponti R; Peroni A; Mola F; Fierro MT; Savoia P; Novelli M; Bernengo MG
Int J Immunopathol Pharmacol; 2009; 22(2):353-62. PubMed ID: 19505389
[TBL] [Abstract][Full Text] [Related]
16. U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease.
Scarisbrick JJ; Taylor P; Holtick U; Makar Y; Douglas K; Berlin G; Juvonen E; Marshall S;
Br J Dermatol; 2008 Apr; 158(4):659-78. PubMed ID: 18241274
[TBL] [Abstract][Full Text] [Related]
17. Extracorporeal photopheresis for paediatric patients experiencing graft-versus-host disease (GVHD).
Rutella S; Valentini CG; Ceccarelli S; Romano MT; Brescia LP; Milano GM; Locatelli F
Transfus Apher Sci; 2014 Jun; 50(3):340-8. PubMed ID: 24780391
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of lymphocytes inactivation by extracorporeal photopheresis using tetrazolium salt based-assay.
Chieregato K; Alghisi A; Borghero C; Elice F; Raimondi R; Zanetti E; Rodeghiero F; Astori G
Transfus Apher Sci; 2015 Oct; 53(2):242-5. PubMed ID: 26051797
[TBL] [Abstract][Full Text] [Related]
19. Extracorporeal photopheresis: technique, established and novel indications.
Marques MB; Adamski J
J Clin Apher; 2014 Aug; 29(4):228-34. PubMed ID: 24828404
[TBL] [Abstract][Full Text] [Related]
20. Real-world use of extracorporeal photopheresis for patients with cutaneous T-cell lymphoma in the United States: 2010-2015.
Ling YL; Huang X; Mitri G; Lovelace B; Pham A; Knobler R; Li X; Gao X
J Dermatolog Treat; 2020 Feb; 31(1):91-98. PubMed ID: 30892982
[No Abstract] [Full Text] [Related]
[Next] [New Search]